Embedded Files
Purpose
Purpose
The Gene Therapy Society of Singapore was set up in 2024 to provide a platform to bring together clinicians, researchers, industry and patients involved in genetic medicine and therapies. Rather than focusing on the scientific community only, the society is also bringing together individuals involved in translation, deployment, advocacy and outreach of gene therapy, so as to be a bridge between cutting edge research and real world impact.
Gene Therapy Society of Singapore seeks to:
Advance & promote the translation of genetic medicine and therapies;
Advocate for availability of genetic medicine to patients;
Enhance public understanding of genetic medicine and therapies.
We hope those of you working on or having an interest in genetic medicine can join us in this society and help shape the direction it moves in.
Upcoming
Upcoming
GTSS Webinar Series 3: Blood Gene Therapy - A/Prof Yen Choo
GTSS Webinar Series 3: Blood Gene Therapy - A/Prof Yen Choo
Dear Members and Colleagues,
Please join us for an exciting GTSS Webinar Series 2: Blood Gene Therapy, featuring a stellar line-up of experts in bench to bedside research and clinical trials (please see below). We are pleased to bring you three talks. The first will be delivered by A/Prof Yen Choo, exploring Direct Reprogramming of iPSCs and somatic cell types into haematopoietic lineages for therapeutic applications.
Date: 25 May 2026 (Monday)
Time: 12.20pm – 1.30pm
Registration is free
Please find the registration link here:
https://nus-sg.zoom.us/webinar/register/WN_8_B3PcSKQf2_4eXwbM2jog
Or use the QR code in the flyer.
Join us for GTSS Webinar Series 3: Blood Gene Therapy
Join us for GTSS Webinar Series 3: Blood Gene Therapy
Posts
Posts
Gene editing: More genetic disease patients could seek gene therapy by 2030s, say researchers (CNA 25th October 2025)
Gene editing: More genetic disease patients could seek gene therapy by 2030s, say researchers (CNA 25th October 2025)
Comment from GTSS: More gene therapy could be available to sufferers of genetic disease in the near future
For archived posts, please click here.
Current Committee (2024-2025)
Current Committee (2024-2025)
President
Assoc Prof Citra Mattar
A clinician-scientist based at National University Hospital Department of Obstetrics and Gynaecology working on fetal gene therapy.
Vice President
Dr Koh Ai Ling
A clinician specializing in pediatric genetics based at the KK Women's and Children's Hospital
Secretary
Asst Prof Chin Hui-Lin
A Consultant with the Division of Genetics and Metabolism, Khoo Teck Puat – National University Children's Medical Institute, National University Hospital.
Treasurer
Asst Prof Gan Shu Uin
A Research Assistant Professor at the Yong Loo Lin School of Medicine - Surgery working on AAV-mediated gene therapy
Committee
Asst Prof Volker Patzel
A Senior Lecturer at the Department of Microbiology and Immunology at the Yong Loo Lin School of Medicine with an interest in RNA Technologies and Delivery
Committee
Dr Seow Yiqi
A Scientist working at the Genomic Institute of Singapore working on gene circuitry
Committee
Asst Prof Kaavya Narasimhalu
Dr Kaavya is a clinician scientist with a focus on Neurogenetics and precision medicine at the SingHealth Duke-NUS Genomic Medicine Centre
Committee
Asst Prof Saumya Jamuar
A Senior Consultant specializing in pediatrics genetics at the KK Woman's and Children's Hospital as well as the Deputy Director (Clinical) at SingHealth Duke-NUS Institute of Precision Medicine
Page updated
Google Sites
Report abuse